Elecsys Afp
Kit, Test,Alpha-Fetoprotein For Testicular Cancer. 510(k) K973351, from Boehringer Mannheim Corp. (Concord, CA). Product code LOJ, class 2.
As of Nov 20, 2026, K973351 is an FDA 510(k) held by Boehringer Mannheim Corp., substantially equivalent on Nov 21, 1997 after 77 days, with no recalls tied to it in FDA's recall database.
- Review time: 77 days
- Recalls: 0
- Cited as a predicate by: 1 device
K973351 Immunoassay for the in vitro quantitative determination of \alpha_{1 -fetoprotein in human serum and plasma to aid in the management of patients with non-seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the Boehringer Mannheim Elecsys immunoassay analyzers.
- P860044P860044
- Elecsys AfpK981282 · Roche Diagnostics GmbH · May 1, 1998
- Elecsys AFPK220176 · Roche Diagnostics · Sep 15, 2022
- Vitros AfpK213626 · Ortho Clinical Diagnostics · Jun 15, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 5, 1997
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files